Finally, the results of flow cell apoptosis assay demonstrated that silencing SFXN3 in AML cells lead to enhanced cell apoptosis in both SKM-1 and MEG-01 cells (Fig. 2I–J). The gene discussed is SFXN3; the disease is acute myeloid leukemia.